Filing Flows › Accendra Health (ACH) › Q2 2025
Accendra Health (ACH) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 11, 2025
Accendra Health (ACH) reported revenue of $682M for the second quarter 2025 (Q2 2025), +3% from a year earlier and -74% from the quarter before. Operating margin was -5.8%, net loss $869M (127.4% of revenue).
Accendra Health, Q2 2025: revenue $682M (+3% year over year), operating margin -5.8%, net loss $869M, operating cash flow $37.6M. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $682M | -74% | +3% |
| Operating profit | −$39.7M | -301% | — |
| Net earnings | −$869M | — | — |
| Operating cash flow | $37.6M | — | -68% |
What changed
Revenue was $681.9M in Q2 2025, up 3% year over year and down 74% from the previous quarter. Diabetes was the largest line at 28% of revenue. Sleep therapy added $11.4M year over year (up 7%), 53% of the total change. Diabetes declined 2%.
Operating costs exceeded revenue by $39.7M, an operating margin of -5.8%. The quarter ended with a net loss of $869.1M, wider than the previous quarter's $25.0M loss. Net interest and other expense of $830.5M was the main reason.
Operating cash flow was $37.6M (down 68% year over year). Non-cash charges added back $59.4M of depreciation and amortization and $8.1M of share-based compensation. Working capital and other items added $839.2M. Capital expenditures of $77.8M exceeded it, leaving free cash flow of −$40.2M.
Questions
What was Accendra Health's revenue in the second quarter 2025?
Accendra Health (ACH) reported revenue of $682M for the second quarter 2025 (Q2 2025), +3% from a year earlier and -74% from the quarter before.
Was Accendra Health profitable in the second quarter 2025?
Operating loss was $39.7M (-5.8% of revenue) and net loss $869M.
Source: Accendra Health 10-Q on SEC EDGAR.